Brian Corvese

CIK 1393207 · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$925.2K

Companies

3

Total Filings

49

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INKT Director 51,693 $12.02 $621.3K $0 19 2026-06-02
AGEN Director 92,085 $3.30 $303.9K $0 27 2026-04-28
Protagenic Therapeutics, Inc.\new (PTIXW) Delisted Director $0.01 $0 1 2024-03-29

Recent Filings · Page 2 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-09-05 INKT Grant (A) +21,802 $17.9K EDGAR
2024-06-18 AGEN Grant (A) $0 EDGAR
2024-06-05 INKT Grant (A) +17,967 $17.8K EDGAR
2024-04-22 AGEN Grant (A) $0 EDGAR
2024-03-29 Protagenic Therapeutics, Inc.\new (PTIXW) Delisted Grant (A) $0 EDGAR
2024-03-05 INKT Grant (A) +18,816 $17.9K EDGAR
2023-12-05 INKT Grant (A) +17,188 $17.9K EDGAR
2023-09-06 INKT Grant (A) +12,244 $17.9K EDGAR
2023-06-16 INKT Grant (A) $0 EDGAR
2023-06-02 INKT Grant (A) +10,157 $17.9K EDGAR
Showing 1120 of 49
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.